In the journey towards a healthier you, discover the transformative power of Tirzepatide also known as Zepbound
In December, the FDA said the tirzepatide shortage had been resolved and removed it from the shortage list
In comparison, patients who used retatrutide (8 mg and 12 mg once weekly) lost 17.5% at 24 weeks and 24.2% of their body weight after 48 weeks in phase 2 clinical trials
FDA-approved GLP-1 medications work by mimicking a natural hormone that enhances insulin secretion, suppresses glucagon, and slows gastric emptying
After month one, most patients expect 48 pounds cumulative loss, with acceleration in months 2 and 3 as doses reach therapeutic levels
Never under any circumstances use this product in an unauthorized or unintended fashion.